ARIMIDEX Trademark

Trademark Overview

On Tuesday, October 11, 2005, a trademark application was filed for ARIMIDEX with the United States Patent and Trademark Office. The USPTO has given the ARIMIDEX trademark a serial number of 78731027. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 22, 2016. This trademark is owned by AstraZeneca UK Limited. The ARIMIDEX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Provision of information and advice relating to the diagnosis and treatment of cancer
arimidex

General Information

Serial Number78731027
Word MarkARIMIDEX
Filing DateTuesday, October 11, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 22, 2016
Registration Number3726705
Registration DateTuesday, December 15, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 13, 2007

Trademark Statements

Indication of Colors claimedThe color(s) black, white, pink, brown, and flesh tones is/are claimed as a feature of the mark.
Description of the Colors ClaimedThe word "ARIMIDEX" and the border of the Oval Designs are black, the remainder of the Oval Designs are in white, the boxing gloves are in pink, the hair on the human figure is brown and her skin in the flesh tones.
Goods and ServicesProvision of information and advice relating to the diagnosis and treatment of cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 22, 2016
Primary Code044
First Use Anywhere DateTuesday, November 12, 2002
First Use In Commerce DateTuesday, November 12, 2002

Trademark Owner History

Party NameAstraZeneca UK Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLondon W1Y 6LN
Party NameAstraZeneca UK Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLondon W1Y 6LN
Party NameAstraZeneca UK Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLondon W1Y 6LN

Trademark Events

Event DateEvent Description
Friday, July 22, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, December 15, 2009REGISTERED-PRINCIPAL REGISTER
Monday, November 9, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, November 9, 2009ASSIGNED TO LIE
Tuesday, October 27, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 21, 2009JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, July 22, 2009EX PARTE APPEAL-INSTITUTED
Wednesday, July 22, 2009EXPARTE APPEAL RECEIVED AT TTAB
Thursday, January 22, 2009NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, January 22, 2009FINAL REFUSAL E-MAILED
Thursday, January 22, 2009SU - FINAL REFUSAL - WRITTEN
Wednesday, December 31, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 31, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 31, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 3, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 3, 2008NON-FINAL ACTION E-MAILED
Thursday, July 3, 2008SU - NON-FINAL ACTION - WRITTEN
Friday, June 6, 2008STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 3, 2008USE AMENDMENT FILED
Tuesday, June 3, 2008TEAS STATEMENT OF USE RECEIVED
Friday, December 28, 2007EXTENSION 1 GRANTED
Wednesday, December 5, 2007EXTENSION 1 FILED
Wednesday, December 5, 2007TEAS EXTENSION RECEIVED
Monday, July 30, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 30, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 5, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2007NOTICE OF PUBLICATION
Monday, January 29, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, January 27, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 27, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 29, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 27, 2007ASSIGNED TO LIE
Friday, December 29, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 24, 2006FINAL REFUSAL E-MAILED
Friday, November 24, 2006FINAL REFUSAL WRITTEN
Wednesday, November 1, 2006AMENDMENT FROM APPLICANT ENTERED
Monday, October 16, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 16, 2006PAPER RECEIVED
Thursday, April 13, 2006NON-FINAL ACTION E-MAILED
Thursday, April 13, 2006NON-FINAL ACTION WRITTEN
Thursday, April 13, 2006ASSIGNED TO EXAMINER
Monday, October 17, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

arimidex treatment cancer diagnosis relating information advice provision